SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new ...
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, many new variants have emerged due to the genomic mutations of the causal agent, namely, severe acute respiratory syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results